ExpreS2ion Financial Statements From 2010 to 2024
| EXPRS2 Stock | SEK 18.74 0.38 1.99% |
Check ExpreS2ion Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ExpreS2ion Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . ExpreS2ion financial statements analysis is a perfect complement when working with ExpreS2ion Biotech Valuation or Volatility modules.
ExpreS2ion |
ExpreS2ion Biotech Holding Company Current Valuation Analysis
ExpreS2ion Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ExpreS2ion Biotech Current Valuation | 361.15 M |
Most of ExpreS2ion Biotech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ExpreS2ion Biotech Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, ExpreS2ion Biotech Holding has a Current Valuation of 361.15 M. This is 97.49% lower than that of the Healthcare sector and 92.23% lower than that of the Biotechnology industry. The current valuation for all Sweden stocks is 97.83% higher than that of the company.
ExpreS2ion Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ExpreS2ion Biotech's current stock value. Our valuation model uses many indicators to compare ExpreS2ion Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ExpreS2ion Biotech competition to find correlations between indicators driving ExpreS2ion Biotech's intrinsic value. More Info.ExpreS2ion Biotech Holding is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value ExpreS2ion Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ExpreS2ion Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About ExpreS2ion Biotech Financial Statements
ExpreS2ion Biotech stakeholders use historical fundamental indicators, such as ExpreS2ion Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although ExpreS2ion Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in ExpreS2ion Biotech's assets and liabilities are reflected in the revenues and expenses on ExpreS2ion Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ExpreS2ion Biotech Holding. Please read more on our technical analysis and fundamental analysis pages.
ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. ExpreS2ion Biotech operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 15 people.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in ExpreS2ion Stock
ExpreS2ion Biotech financial ratios help investors to determine whether ExpreS2ion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ExpreS2ion with respect to the benefits of owning ExpreS2ion Biotech security.